lunes, 12 de agosto de 2024

Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study

https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00166-2/abstract?utm_campaign=update-lanhae&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanhae&_hsenc=p2ANqtz-8kaDFMzIzz0UvCeKxqWPhcWoo5AT9DqwScVZ0AGfDVkkKscgtBoalBR2Vp1v_CeBaa1HSDSq8lh7A_JnebeJ31wSQLFQ&_hsmi=319615056&utm_content=319423428&utm_source=hs_email

No hay comentarios:

Publicar un comentario